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Abstract
Summary The timed up and go (TUG) test measures physical performance and predicts falls in the elderly. In older women, TUG
time predicts the risk of major osteoporotic fracture and hip fracture independently of clinical risk factors and bone mineral
density, and has a substantial impact on fracture probabilities.
Introduction The timed up and go (TUG) test measures physical performance and predicts falls in the elderly. A slow TUG has
been associated with an increased fracture risk, but it is unclear whether the association is independent of clinical risk factors and
bone mineral density (BMD). The aim of this study was to investigate if TUG time was associated with fracture risk indepen-
dently of clinical risk factors and BMD and to determine its impact on fracture probabilities in older women.
Methods A standardized questionnaire was used to assess information regarding clinical risk factors in the large population-
based SUPERB study of 3028 older women (75–80 years). At baseline, the TUG test was performed and BMD measured with
DXA. The association between TUG time and the risk of hip fracture andmajor osteoporotic fracture (MOF) was examined using
an extension of Poisson regression.
Results Fracture incidence increased steeply with increasing TUG time up to 12 s and subsequently started to level off. A slow
TUG time was therefore defined as TUG > 12 s, a cutoff level then used in Cox models to study the association between slow
TUG and fracture risk. A slow TUG time was associated with an increased risk of fracture (MOF 2.39 [1.80–3.18] and hip
fracture 2.96 [1.62–5.40]). These associations were slightly attenuated but remained significant after adjustment for clinical risk
factors and femoral neck BMD. Depending on BMD, the 4-year fracture probability of MOF increased by a factor of 1.5–1.9 in a
75-year-old woman with slow TUG (> 12 s).
Conclusion The TUG time predicts the risk of MOF and hip fracture independently of clinical risk factors and BMD and has a
substantial impact on fracture probabilities, indicating that inclusion of the TUG test in patient evaluation should be considered in
order to improve fracture prediction in older women.
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Introduction
Fractures in older women constitute a serious health risk, and
often cause great suffering both in short and long term for the
affected individuals [1, 2]. Additionally, patients with hip frac-
ture often experience loss of physical function, decreased social
engagement, increased dependence, and worsened quality of life
[3–5]. A large proportion of patients who have had a hip fracture
are forced to alter their living conditions, which could involve
relocating from their home into a residential aged care facility,
having extensive impact on the affected person’s autonomy
[6–8]. Furthermore, all fractures and especially hip fractures in-
crease the risk of mortality and morbidity in older men and
women [9]. The etiology of fracture involves both bone fragility
and fall risk. For each standard deviation (SD) decrease in bone
mineral density (BMD) as assessed using dual-energy x-ray ab-
sorptiometry (DXA) in the femoral neck, the risk of hip fracture
is increased nearly 3-fold [10]. Osteoporosis, sarcopenia, and
reduced physical performance become more prevalent with in-
creasing age and therefore contribute to the increasing risk of fall
injuries and fractures with aging [11, 12]. Over 70% of all frac-
tures affect women older than 65 years [13]. Risk factors for falls
such as immobility and previous falls also contribute to the risk
of fractures in the elderly [14, 15]. Identifying individuals who
will fracture based on BMD alone has low sensitivity [16].
Therefore, fracture risk calculators which incorporate clinical
risk factors in addition to BMD have been developed in recent
years. Among those, the fracture risk assessment tool FRAX is
the most widely used [17]. The timed up and go test (TUG)
measures physical performance and has been used to identify
frail older individuals. A slow TUG time (> 10 s) was associated
with increased risk of fracture in a large study of Australian
women, an association independent of BMD and some clinical
risk factors [18]. However, the most appropriate cutoff time to
define slow TUG time in relation to fracture risk has not been
established. It is also not known if assessment of TUG time
contributes independently to fracture risk when all clinical risk
factors incorporated in FRAX are considered and to what extent
TUG time affects fracture probability. The aim of the present
work was to study the relationship between TUG time and risk
of fracture, to investigate if TUG independently contributes to
fracture risk when also considering all clinical risk factors cur-
rently included in FRAX and femoral neck BMD, and to deter-
mine to which extent TUG time contributes to the over-all frac-
ture probability in older women.
Materials and methods
Subjects
SUPERB—Sahlgrenska University Hospital Prospective
Evaluation of the Risk of Bone fractures—is a prospective
population-based study, carried out in the greater Gothenburg
area. The study comprises 3028 women, 75–80 years old [19].
Women were chosen randomly from the Swedish national pop-
ulation register. All subjects signed an informed consent, prior
to participation. The study protocol has been approved by the
regional Ethics Review Board in Gothenburg. The criteria for
being invited to the Study Clinic (Department of Geriatrics,
Sahlgrenska University Hospital, Mölndal, Sweden) were as
follows: (1) acceptance of the invitation sent by letter and pro-
viding a positive response to the follow-up telephone call, (2)
be able to attend the clinic visit and being ambulatory, (3)
understand Swedish, (4) being a woman between the age of
75 and 80 years.
Anthropometrics and TUG test
Body height was measured using a wall-mounted calibrated
stadiometer. Body weight was measured to the nearest 0.1 kg
using the same scale in all women. The timed up and go
(TUG) test investigates balance and mobility [20, 21]. The
participants were timed (in seconds) starting when rising from
sitting in a chair, 45 cm high, equipped with armrests, walking
3 m in normal pace, turning around, walking back, and sitting
down again. The time for this procedure was recorded. They
could use their regular footwear and were allowed to utilize
any mobility aids that they normally required. The TUG test
was performed by 3004 participants, and 24 could not accom-
plish the test.
Questionnaires
Data regarding medical and fracture history, physical activity,
occurrence of falls in the last 12months, alcohol consumption,
parental history of hip fracture, oral glucocorticoid use, alco-
hol consumption, and calcium intake were collected using
questionnaires. Self-reported fractures after the age of 50 years
at any location, except the skull and face, were included in the
FRAX score calculations. Current smoking was defined using
a validated questionnaire [22]. A small proportion of partici-
pants (≈ 1.6%) could not recall if a parent had sustained a hip
fracture. A null response was assumed in those cases. A high
alcohol consumption was defined as 21 standard drinks per
week or more [23]. Mental and physical health (MC12 and
PCS12) related quality of life was assessed using SF12 Health
Survey [24–26]. The validated questionnaire Physical
Activity Scale for the Elderly (PASE) was used to estimate
physical activity in the last 7 days before the inclusion in the
study [27]. PASE is a self-reported questionnaire which tar-
gets individuals over the age of 65 years. Participation (yes/
no) or the number of hours spent in an activity is multiplied by
given weights, thus giving a total score. The daily calcium
intake was assessed and estimated in a validated question-
naire, by adding the food-derived calcium intake to the
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amount of calcium provided by supplements [28]. No infor-
mation regarding vitamin D intake or sunlight exposure was
available.
Dual-energy x-ray absorptiometry measures
Bone density measurements were performed using the same
DXA device for most participants (n = 2995) (Discovery A S/
N 86491; Hologic, Waltham, MA, USA). Owing to a tempo-
rary machine failure, a few women (n = 33) were measured
using another Discovery A Hologic DXA device. A cross-
calibration was performed between the two instruments and
has been reported elsewhere [19]. The areal BMD (aBMD)
(g/cm2) of the femoral neck (FN) and lumbar spine (LS) were
used in the analyses. Lateral scan imaging at baseline was
performed using DXA with the participant in the supine posi-
tion, in order to diagnose vertebral fractures, using the soft-
ware program Physician’s Viewer (Hologic) as previously
described [29]. After assessment of the anteroposterior lum-
bar, vertebrae which were fractured and/or contained
osteosynthesis materials in the LS (L1 to L4) were excluded.
The LS aBMD was calculated as the mean of L1 to L4 if at
least two vertebrae were assessable. The coefficients of vari-
ation (CV) were for aBMD FN and aBMD LS, 0.7% and
1.3%, respectively. The 4- and 10-year probabilities of MOF
(major osteoporotic fractures; included fractures of the spine,
hip, forearm, and proximal humerus) for women 75 and
80 years old were calculated according to femoral neck
BMD T-score [30]. The National Health and Nutrition
Examination Survey (NHANES) III reference database for
total hip and femoral neck in young (20–29-year-old)
Caucasian women and the Hologic sample for lumbar spine
measurements comprising 30-year-old Caucasian American
women were used to calculate the corresponding T-scores
[31, 32].
Biochemical analyses
Blood samples were drawn from all study participants, and
serum was separated, aliquoted, and stored at − 80 °C until
analyses. Serum 25-hydroxyvitamin D, calcium, and parathy-
roid hormone (PTH) were analyzed at the Department of
Clinical Chemistry (Swedac accredited no. 1342), Linköping
University Hospital, Sweden, and all samples were assayed
with reagents from the same batch. Serum 25-hydroxyvitamin
D was measured on the DiaSorin LIAISON® XL analyzer
with the 25-hydroxyvitamin D total chemiluminescence im-
munoassay (DiaSorin, Stillwater, MN, USA), which demon-
strates 100% cross-reactivity for 25-hydroxyvitamin D2 and
25-hydroxyvitamin D3. The assay performances were analyt-
ical range 10–375 nmol/L, and total CVs of 8.8%, 6.4%, and
6.8% at levels 25 nmol/L, 68 nmol/L, and 150 nmol/L, respec-
tively. Serum intact PTH was determined using the Elecsys
electrochemiluminescence immunoassay on a Roche Cobas
e601 platform (Roche Diagnostics Scandinavia AB,
Gothenburg, Sweden), which has the following assay perfor-
mance: analytical range 0.13–530 pmol/L, and total CVs of
4.0%, and 2.9% at levels 1.9 pmol/L and 8.6 pmol/L,
respectively.
Incident fracture assessment
Incident fractures were verified using radiographs. X-ray re-
ports and/or images were retrieved from a regional digital X-
ray archive that included all the 49municipalities in the Västra
Götaland region surrounding Gothenburg. All the radiology
reports were initially reviewed by research nurses between the
baseline exam until May 24, 2018. All reported fractures were
recorded and all radiographs without available radiology re-
ports or reports with uncertain fracture diagnosis were exam-
ined by an experienced orthopedic surgeon. Major osteopo-
rotic fractures included clinical spine, hip, forearm, and prox-
imal humerus fractures. Nonvertebral fractures included all
fractures, except for fractures of the spine, skull, face, hand,
and foot.
Statistical analyses
For continuous variables, independent samples t tests were
used to examine differences between groups. χ2 and
Fisher’s exact tests were used for dichotomous variables.
The association between TUG as a continuous variable and
the risk of fracture was examined using an extension of the
Poisson regression model in the whole cohort [33, 34]. The
hazard function for major osteoporotic fracture and death was
calculated using a modification of the Poisson regression
model. For fracture, the variables in the hazard function were
current time since baseline, current age, BMI, previous frac-
ture, family history of hip fracture, smoking, corticosteroids,
rheumatoid arthritis, alcohol use, and BMD. One additional
model was constructed using the variables mentioned before
adding slow TUG (0/1). For death, the variables in the hazard
function were current time since baseline, current age, BMI,
current smoking, per oral corticosteroid use, and BMD. Also,
here, one additional model was constructed adding slow TUG
(0/1). From the hazard functions for fracture and death, the 10-
year probability of major osteoporotic fracture was calculated
[35]. Follow-up is approximately 4 years for the SUPERB
cohort, so when calculating 10-year probability, the hazard
functions were extrapolated in time. It is important to note that
the probability models used were based on purpose-built
models similar to, but not identical to FRAX. The observation
period of each participant was divided in intervals of 1 month.
The first fracture per person was counted for each relevant
outcome. Covariates included current age and time since start
of follow-up. In order to study the association between TUG
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and fracture risk in more detail, a spline Poisson regression
model was fitted using cohort-specific knots at the 10th, 50th,
and 90th percentiles of BMI, as recommended by Harrell [36].
The splines were second-order functions between the
breakpoints and linear functions at the tails resulting in a
smooth curve. The difference in log likelihood values using
the spline and linear models were tested, in order to determine
which model provides the most optimal curve-fit. The value
considered significant was a p value less than 0.05. Incidence
per 1000 person-years was calculated as number of events
divided by total follow-up time (until fracture, death, or cen-
sored) per 1000 years. Associations between TUG (TUG ≤
12 s or > 12 s) and incident fractures were also studied using
Cox proportional hazard models adjusted for age, height and
weight as well as additional covariates, including all FRAX
clinical risk factors (previous fracture, family history of hip
fracture, current smoking, oral glucocorticoid use, rheumatoid
arthritis, excessive alcohol intake), osteoporosis medication
and history of falls, and censored for death or end of study
(May 24, 2018). Hazard ratios (HR) and 95% confidence in-
tervals derived from Cox models are presented. Statistical
analyses were performed using SPSS Statistics Version 24
(IBM Corporation, Armonk, NY, USA). The hazard function
developed by Fine and Gray was used to assess death as a
competing risk for osteoporotic fractures [37]. For the calcu-
lations according to Fine Gray, STATA, Statistics/Data
Analysis, version 16.0, serial number 401609206078, li-
censed to the University of Gothenburg, was used.
Results
Baseline characteristics and TUG time
During a median follow-up of 3.6 (Interquartile range, IQR
1.48) years, 335 women sustained a MOF, 314 a nonvertebral
fracture, and 66 women a hip fracture. In the whole cohort
(n = 3004), median TUG time was 8.00 (IQR 2.6) seconds.
The relationship between TUG and incident MOF and hip
fracture showed a steep increase in fracture risk with TUG
up to about 12 s (Fig. 1a and b) and then started to level off.
The spline function provided a significantly improved curve-
fit in comparison to a linear function for MOF (p = 0.01), but
the improvement was only borderline significant for hip frac-
ture (p = 0.05).
We therefore choose TUG above 12 s as the cutoff and
divided the women with available TUG into two groups,
TUG time ≤ 12 s (n = 2711) and TUG time > 12 s (n = 293).
Characteristics of women with TUG ≤ 12 s and women with
TUG > 12 s at baseline are presented in Table 1. Women with
TUG > 12 s were older, shorter, and heavier than women with
TUG ≤ 12 s. Physical activity and physical and mental health
were inferior, while calcium and PTH were higher among
those with slow TUG. Prevalence of falls, self-reported prior
fracture, rheumatoid arthritis, hyperthyroidism, self-reported
osteoporosis, hypertension, stroke, myocardial infarction, an-
gina, heart failure, type 2 diabetes, chronic bronchitis/asthma/
emphysema, and women using osteoporosis medication were
all more common among those with TUG > 12 s (p < 0.05),
indicating an increased comorbidity in this group of women.
A slow TUG time was associated with a higher fracture
incidence
The incident fractures were divided into three groups;
nonvertebral fracture, MOF, and hip fracture. The incidence
of nonvertebral fracture, MOF, and hip fracture was substan-
tially higher in women with TUG > 12 s than in women with
faster TUG. Cox proportional hazard models adjusted for age,
height, and weight demonstrated that TUG > 12 s was associ-
ated with increased risk of nonvertebral fracture (hazard ratio
(HR) and 95% confidence interval (CI) 2.09 [1.53–2.84]),
MOF (HR, 95% CI 2.39 [1.80–3.18]), and hip fracture (HR
95% CI 2.96 [1.62–5.40]). These associations were somewhat
attenuated but remained significant also after adjustments for
clinical risk factors included in FRAX, use of osteoporosis
medication, prior falls, and femoral neck BMD (Table 2).
The impact of TUG > 12 s on fracture probabilities
Study subject follow-up time was extrapolated up to 10 years
to allow for calculations of 10-year fracture probability. The
10-year probabilities of MOF for women 75 and 80 years old
were calculated, setting BMI to 26 kg/m2, previous fracture
set to yes, and all other clinical risk factors set to no, according
to femoral neck BMD T-score, with or without consideration
to TUG (≤ 12 s or > 12 s) in the analysis. For a 75-year-old
woman with BMD T-score − 2, a slow TUG > 12 s increased
the 10-year probability substantially, from 34.3 to 47.5%. The
equivalent 10-year probability for an 80-year-old woman with
a T-score of − 2 was 37.3% and 48.7%, for TUG ≤ 12 s or >
12 s, respectively (Fig. 2 a, b). The 4-year probabilities of
MOF for women 75 and 80 years old, with previous fracture,
BMI of 26 kg/m2, and no additional clinical risk factors, were
also calculated according to femoral neck BMD T-score, with
or without consideration to TUG (≤ 12 s or > 12 s) in the
analysis. For a 75-year-old woman with BMD T-score − 2,
TUG > 12 s was associated with a markedly higher 4-year
probability (14% vs. 24%). The corresponding 4-year proba-
bility for an 80-year-old woman with a T-score of − 2 was
16% and 26%, for TUG ≤ 12 s or > 12 s, respectively (Fig.
2c, d). The ratios between the calculated 4-year probability
without considering TUG and with TUG > 12 s for women
75 and 80 years old, with previous fracture, BMI of 26 kg/m2
but no other clinical risk factors, according to femoral neck
BMDT-score, are presented in Fig. 3. The relative importance
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on fracture probability of having TUG > 12 s increased with
BMD in both 75- and 80-year-old women.
The impact of competing risk of death according to
Fine and Gray
The association between TUG > 12 and risk for major osteo-
porotic fracture (subhazard ratio (SHR) and 95% CI 2.31
(1.73–3.09)), hip fracture (SHR 2.85 (1.56–5.22)), and
nonvertebral fracture (SHR 2.01 (1.47–2.76)) did not change
substantially when a competing risk survival regression mod-
el, adjusted for age, height, and weight, was applied.
Discussion
In the present study, we demonstrate that TUG is an indepen-
dent predictor of nonvertebral fracture, MOF, and hip fracture,
and that these associations are independent of clinical risk
factors included in FRAX and BMD of the femoral neck.
Fracture risk increased progressively with TUG time and
started to level off when TUG time exceeded 12 s. Having a
slow TUG time (> 12 s) had a substantial impact, on the prob-
ability of MOF and hip fracture, indicating that evaluation of
TUG could be useful in determining fracture risk in older
women.
Although the spline functions describing the relationship
between TUG and MOF or hip fracture provided better curve
fits than linear models, the proposed and used cutoff of 12 s is
clearly not perfect, since it is evident that the risk of fracture
progresses further with TUG time slower than 12 s. It should
be acknowledged that the spline model herein presented for
hip fracture is based on few fractures (n = 66) with resulting
large confidence intervals. However, it can be argued that
deriving the cutoff using spline models for fracture risk is
superior to, as previously done, using age-specific means
without any consideration of fracture risk [18, 20].
FRAX is the most widely used fracture risk assessment tool
for estimating individualized 10-year probability of hip and
major osteoporotic fracture [30, 38–41]. The calculated 10-
year fracture probability is based on clinical risk factors with
or without BMD, and recommended in many clinical guide-
lines to calculate the probability of a MOF or hip fracture [41,
42]. In the presently investigated cohort, a slow TUG time (>
12 s) increased the 10-year probability substantially in women
of all ages and with low to normal BMD, to risk levels above
the 20%, a commonly used treatment threshold [42]. Thus,
performing the TUG test and considering TUG time would
have a substantial impact on treatment decisions in women in
this age group.
TUG performance is known to capture several different
aspects of aging, such as poor balance, falls, and disability
of daily living [43–46]. TUG time has been shown to be able
to predict frailty with high sensitivity and specificity but is to a
lesser extent able to discriminate fallers from non-fallers [47,
48]. In the present study, it was apparent that women with a
slow TUG time (> 12 s) had a considerably poorer general
health than womenwith normal TUG, as indicated by a higher
BMI, worse physical and mental quality of life, as well as
more prevalent falls and fractures, type 2 diabetes, stroke,
osteoporosis, Parkinson’s disease, myocardial infarction, and
heart failure. Thus, a slow TUG time served as a proxy for
worse general health and can therefore be used to efficiently
identify physical frailty which negatively impacts the risk of
falls and fractures.
It can be problematic to identify risk factors in older pop-
ulations with considerable comorbidities and a high mortality
rate, due to the competing risk of death [49]. In the herein
presented analysis, we also performed analysis of the relation-
ship between TUG time and incident fracture, using the Fine
and Gray method, to adjust for competing mortality. The ro-
bust associations between TUG and fracture risk remained
when considering competing mortality, supporting the notion
that TUG performance is useful to test also in this age group.
Fig. 1 a The relationship between timed up and go (TUG) time and
incidence of major osteoporotic fracture (MOF). Incidence and 95% con-
fidence intervals of MOF according to TUG (seconds) is described per
100,000 person-years. b The relationship between timed up and go
(TUG) time and incidence of hip fracture. Incidence and 95% confidence
intervals of hip fracture according to TUG (seconds) is described per
100,000 person-years
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Table 1 Characteristics of older women with timed up and go (TUG) ≤ 12 s and > 12 s
TUG ≤ 12 s (n = 2711) TUG > 12 s (n = 293) p valuea
Age (years) 77.7 ± 1.6 78.2 ± 1.6 < 0.001
Height (cm) 162.0 ± 5.7 160.2 ± 6.5 < 0.001
Weight (kg) 68.1 ± 11.5 74.4 ± 15.3 < 0.001
Body mass index (kg/m2) 25.9 ± 4.2 29.0 ± 5.5 < 0.001
FN aBMD (g/cm2) 0.66 ± 0.10b 0.65 ± 0.12 0.041
Hip aBMD (g/cm2) 0.80 ± 0.11b 0.78 ± 0.13g < 0.001
Lumbar spine aBMD (g/cm2) 0.94 ± 0.16f 0.98 ± 0.18h < 0.001
FRAX MOF w/o BMD (%) 30.8 ± 12 30.3 ± 12 0.50
FRAX hip fracture w/o BMD (%) 18.0 ± 12 16.9 ± 12 0.12
FRAX MOF with BMD (%) 22.7 ± 12 25.1 ± 13 < 0.01
FRAX hip fracture with BMD (%) 10.8 ± 11 12.3 ± 12 < 0.01
PASE 108.4 ± 50.0b 67.9 ± 41.6g < 0.001
PCS 46.6 ± 10.1 32.9 ± 9.4g < 0.001
MCS 54.0 ± 8.9 49.7 ± 11.9g < 0.001
Calcium intake (from dairy products), mg/day 397 ± 362 313 ± 381 < 0.01
Fall accident within the last year, % 26.7i 53.4j < 0.001
Self-reported prior fracture, % φ 35.8 k 45.7l < 0.001
Parental history of hip fracture, % 17.5m c 17.3n 0.922
Current smoking, % 5.0 6.5o 0.263
Excessive alcohol consumption, % χ 0.6p 0.3q 1.000e
Blood biochemistry (serum)
Creatinine (μmol/L) 76.7 ± 15.7 85.6 ± 32.5g < 0.001
Calcium (mmol/L) 2.47 ± 0.1 2.49 ± 0.1g 0.016
25-Hydroxyvitamin D3 (nmol/L) 62.5 ± 21.0 60.6 ± 23.4
g 0.143
PTH (pmol/L) 4.90 ± 2.0 6.30 ± 3.6 < 0.001
Medications
Glucocorticoid use, % ψ 3.4r 2.8s 0.564
Osteoporosis medication, % ω 9.7 t 17.2u < 0.001
Medical history
Rheumatoid arthritis, % 3.4r 7.5v < 0.001
Hyperthyroidism, % 4.8w 7.9x 0.020e
Osteoporosis, % ϊ 18.7y 34.6z < 0.001
Hypertension, % 51.5α 59.2β 0.012
Stroke, % 5.8γ 17.5 u < 0.001
Myocardial infarction, % 4.1δ 11.3ε < 0.001
Angina, % 4.6ζ 12.7η < 0.001
Heart failure, % 7.8θ 18.2ι < 0.001
Parkinson’s disease, % 0.52κ 3.4λ < 0.001e
Type 2 diabetes, % 8.9μ d 17.1u < 0.001
Chronic bronchitis, asthma, emphysema, % 9.2π 16.8n < 0.001
Cancer, % 20.6ρ 21.2ς 0.811
Glaucoma, % 8.0σ 8.9τ 0.579
Values are presented as mean ± standard deviation for continuous variables and as percentage and number for categorical variables. Significance was
defined by a p value < 0.05 and significant values are italicized
aCategorical variables χ2 test; b 2699; c 2673; d 2709; eFisher’s exact test; f 2693; g 292; h 285; i 724; j 156; k 967; 135; l 133; m 469; n 49; o 19; p 16; q 1;
r 92; s 8; t 262; u 50; v 22; w 129; x 23; y 506; z 101; 2710; α 1395; β 173; γ 157; δ 110; ε 33; ζ 125; η 37; θ 211; ι 53; κ 14; λ 10; μ 242; π 248; ρ 559; ς 62;
σ 216, τ 26, φ after 50 years of age, fractures of the skull and face are excluded, χ 21 or more units per week; ψ daily oral treatment with at least 5 mg
prednisolone (or equivalent) for 3 months or more ever; ω current treatment with bisphosphonates, teriparatide, or denosumab; ϊ Self-reported—been
diagnosed with osteoporosis, TUG timed up and go, FN femoral neck, PASE Physical Activity Scale for the Elderly, MCS Mental health Component
Scale, PCS Physical Health Component Scale
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In a randomized controlled trial of older women (age
75 years) investigating the effect of calcium supplementation
on fracture risk, TUG was associated with incident fractures
after adjusting for calcium treatment and several other risk
factors and covariates, including BMD [18]. In a recent, very
large study (n = 1,070,320) of male and female Koreans,
66 years old, a slow TUG time (≥ 10 s) was found to be
associated with a modest 21% increased risk of hip fracture
and a 7% increased risk in vertebral fracture, compared to
those with a faster TUG time [50]. In contrast to the analysis
in the present study, neither of these previous studies
attempted to investigate and identify the appropriate thresh-
old, most strongly associated with an elevated fracture risk.
Furthermore, all risk factors presently included in FRAXwere
not considered and the impact of TUG on the over-all fracture
probability was not assessed in these studies [18, 50].
This study has some limitations. The inclusion criteria re-
quired that women were older (75–80 years old), were
ambulatory, and able to understand Swedish. Thus, the results
may not apply to women in other age groups, residing in
nursing homes or with other ethnic backgrounds. Although
women with walking aids were included, women with more
severe disability (not able to walk at all) were excluded. The
TUG test was not available in all women in this study, but a
very large proportion were able to complete the test (3004 out
of 3028) demonstrating its usefulness in this population. The
prevalence of a slow TUG is likely higher in women with a
higher prevalence of disability but lower in younger women.
The importance of TUG as predictor of fracture in such pop-
ulations could be different from the herein investigated
population.
This study also has strengths. It is a large population-based,
prospective study, comprising over 3000 older women, a pop-
ulation with very high fracture risk. All identified fractures
were confirmed using x-rays or radiology reports, ensuring
high quality of the fracture data. It is the first study to
Table 2 Associations between
TUG time > 12 s and fracture risk
in older women
TUG ≤ 12 s (n = 2711) TUG > 12 s (n = 293)
Nonvertebral fracturea
No. (%) 262 (9.7) 52 (17.7)
Rate per 1000 person-years 28.6 54.5
Time at risk, median (IQR), years 3.4 (1.68) 3.3 (1.54)
HR (95% CI)
Adjusted for age, height, weight (model 1) 1 [Reference] 2.09 [1.53–2.84]
+ Clinical risk factors (model 2) 1 [Reference]b 1.61 [1.16–2.23]c
+ FN BMD (model 3) 1 [Reference]d 1.45 [1.04–2.02]e
Major osteoporotic fracture
No. (%) 271 (10.0) 64 (21.8)
Rate per 1000 person-years 29.7 67.9
Time at risk, median (IQR), years 3.4 (1.68) 3.3 (1.62)
HR (95% CI)
Adjusted for age, height, weight (model 1) 1 [Reference] 2.39 [1.80–3.18]
+ Clinical risk factors (model 2) 1 [Reference]b 1.96 [1.45–2.65]c
+FN BMD (model 3) 1 [Reference]d 1.76 [1.30–2.40]e
Hip fracture
No. (%) 51 (1.9) 15 (5.1)
Rate per 1000 person-years 5.3 14.6
Time at risk, median (IQR), years 3.6 (1.28) 3.5 (1.61)
HR (95% CI)
Adjusted for age, height, weight (model 1) 1 [Reference] 2.96 [1.62–5.40]
+ Clinical risk factors (model 2) 1 [Reference]b 2.66 [1.40–5.08]c
+ FN BMD (model 3) 1 [Reference]d 1.93 [1.00–3.71]e
Associations were studied using Cox proportional hazard models. Hazard ratios (HR) and 95% confidence
intervals (CI) are presented. Model 1: adjusted for age, height, and weight. Model 2: adjusted for age, height,
weight, and clinical risk factors included in FRAX (previous fracture, family history of hip fracture, current
smoking, oral glucocorticoid use, rheumatoid arthritis, excessive alcohol intake), osteoporosis medication, and
history of falls. Major osteoporotic fractures included fractures of the spine, hip, forearm, and proximal humerus.
Model 3: adjusted all covariates used in model 2 with the addition of FN BMD
aExcluding fractures of the skull, face, hand and foot; b 2661; c 279; d 2649; e 278
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investigate and present results on the impact of TUG perfor-
mance on fracture probability, also after considering all cur-
rently used FRAX clinical risk factors and BMD. However,
additional similar studies and meta-analyses will be required
to determine if TUG performance could provide additional
value to future FRAX-models.
In conclusion, the present study demonstrates that TUG
time is strongly associated with hip, MOF, and nonvertebral
fractures in older women, also after adjustments for all FRAX
clinical risk factors and BMD. These results indicate that TUG
performance could be included as a routine clinical assess-
ment in order to improve fracture prediction in older women.
Fig. 2 10-year (a, b) and 4-year (c, d) probability of major osteoporotic
fracture according to femoral neck BMD and TUG time. a, b 10-year
probability of a major osteoporotic fracture (MOF) in a 75-year-old (a) or
80-year-old (b) woman according to T-score of femoral neck BMD. The
symbol (closed circle) denote probabilities calculated without TUG and
the lines the range of probabilities with TUG > 12 and TUG ≤ 12 using
the model incorporating TUG. In the used model, BMI is set to 26 kg/m2,
previous fracture to yes, but all other clinical risk factors set to no. c, d 4-
year probability of a major osteoporotic fracture (MOF) in a 75-year-old
(c) or 80-year-old (d) woman according to T-score of femoral neck BMD.
The symbol (closed circle) denote probabilities calculated without TUG
and the lines the range of probabilities with TUG > 12 and TUG ≤ 12
using the model incorporating TUG. In the used model, BMI is set to
26 kg/m2, previous fracture to yes, but all other clinical risk factors set to
no
Fig. 3 The ratio between the 4-
year probability of major osteo-
porotic fracture with and without
considering TUG time is depen-
dent on femoral neck BMD. The
ratio between the 4-year proba-
bility of major osteoporotic frac-
ture with TUG > 12 s and without
considering TUG, shown for
women 75 and 80 years old ac-
cording to femoral neck BMD T-
score. In the used model, BMI is
set to 26 kg/m2, previous fracture
to yes, but all other clinical risk
factors set to no
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